Agilent Technologies (A) Expected to Announce Quarterly Earnings on Wednesday

Agilent Technologies (NYSE:A) will likely be announcing its Q1 2026 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $1.37 per share and revenue of $1.8080 billion for the quarter. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same period last year, the company earned $1.46 earnings per share. The firm’s revenue was up 9.4% compared to the same quarter last year. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Agilent Technologies Stock Performance

Shares of A opened at $123.75 on Wednesday. The stock has a market capitalization of $35.00 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 3.65 and a beta of 1.30. Agilent Technologies has a 12 month low of $96.43 and a 12 month high of $160.27. The firm has a fifty day simple moving average of $137.17 and a 200 day simple moving average of $135.68. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is currently 22.32%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on A. JPMorgan Chase & Co. lifted their target price on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. UBS Group boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $164.50.

Insiders Place Their Bets

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president directly owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Institutional Trading of Agilent Technologies

A number of hedge funds have recently modified their holdings of the stock. Schonfeld Strategic Advisors LLC grew its stake in Agilent Technologies by 3,940.2% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 396,145 shares of the medical research company’s stock valued at $53,903,000 after buying an additional 386,340 shares during the last quarter. Polar Asset Management Partners Inc. acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $3,987,000. DV Equities LLC bought a new position in shares of Agilent Technologies during the fourth quarter worth approximately $54,000. EFG International AG acquired a new stake in Agilent Technologies during the 4th quarter worth approximately $403,000. Finally, Cetera Investment Advisers boosted its stake in Agilent Technologies by 19.9% in the 4th quarter. Cetera Investment Advisers now owns 47,694 shares of the medical research company’s stock valued at $6,490,000 after purchasing an additional 7,907 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.